Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a systematic review
- PMID: 30464474
- PMCID: PMC6214599
- DOI: 10.2147/NDT.S178839
Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a systematic review
Abstract
This systematic review aimed to evaluate the efficacy of neurofeedback (NF) compared to stimulant medication in treating children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Included in this review are eight randomized controlled trials that compared an NF condition, either alone or combined with medication, to a medication condition, which was mainly methylphenidate. Outcome measures included behavioral assessments by parents and teachers, self-reports, neurocognitive measures, electroencephalogram power spectra and event-related potentials. When only trials are considered that include probably blinded ratings or those that are sham-NF or semi-active controlled or those that employed optimally titration procedures, the findings do not support theta/beta NF as a standalone treatment for children or adolescents with ADHD. Nevertheless, an additive treatment effect of NF was observed on top of stimulants and theta/beta NF was able to decrease medication dosages, and both results were maintained at 6-month follow-up. This review concludes that the present role of NF in treating children diagnosed with ADHD should be considered as complementary in a multimodal treatment approach, individualized to the needs of the child, and may be considered a viable alternative to stimulants for a specific group of patients. Particularly patients with the following characteristics may benefit from NF treatment: low responders to medication, intolerable side effects due to medication, higher baseline theta power spectra and possibly having no comorbid psychiatric disorders. Future research should prioritize the identification of markers that differentiate responders from nonresponders to NF treatment, the potential of NF to decrease stimulant dosage, the standardization of NF treatment protocols and the identification of the most favorable neurophysiological treatment targets.
Keywords: ADHD; EEG; biofeedback; methylphenidate; randomized trials; theta/beta training.
Conflict of interest statement
Disclosure The author reports no conflicts of interest in this work.
Figures
Similar articles
-
Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.Nord J Psychiatry. 2017 Jul;71(5):386-394. doi: 10.1080/08039488.2017.1305446. Epub 2017 Mar 27. Nord J Psychiatry. 2017. PMID: 28345387 Clinical Trial.
-
A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.J Child Psychol Psychiatry. 2016 May;57(5):633-44. doi: 10.1111/jcpp.12517. Epub 2016 Jan 8. J Child Psychol Psychiatry. 2016. PMID: 26748531 Clinical Trial.
-
A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol. 2016 May;26(4):344-53. doi: 10.1089/cap.2015.0144. Epub 2016 Jan 15. J Child Adolesc Psychopharmacol. 2016. PMID: 26771913 Clinical Trial.
-
EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials.Front Hum Neurosci. 2014 Nov 13;8:906. doi: 10.3389/fnhum.2014.00906. eCollection 2014. Front Hum Neurosci. 2014. PMID: 25431555 Free PMC article. Review.
-
A review of neurofeedback treatment for pediatric ADHD.J Atten Disord. 2012 Jul;16(5):351-72. doi: 10.1177/1087054711427530. Epub 2011 Nov 16. J Atten Disord. 2012. PMID: 22090396 Review.
Cited by
-
Impact of Mobile Neurofeedback on Internet Addiction and Neurocognitive Function in Neurotypical Children: Double-Blind, Sham-Controlled Randomized Clinical Trial.Neuropsychiatr Dis Treat. 2024 May 17;20:1097-1106. doi: 10.2147/NDT.S454881. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38774254 Free PMC article. Clinical Trial.
-
Psychological Treatments for Hyperactivity and Impulsivity in Children with ADHD: A Narrative Review.Children (Basel). 2023 Sep 27;10(10):1613. doi: 10.3390/children10101613. Children (Basel). 2023. PMID: 37892276 Free PMC article. Review.
-
Variations in Theta/Beta Ratio and Cognitive Performance in Subpopulations of Subjects with ADHD Symptoms: Towards Neuropsychological Profiling for Patient Subgrouping.J Pers Med. 2023 Sep 7;13(9):1361. doi: 10.3390/jpm13091361. J Pers Med. 2023. PMID: 37763129 Free PMC article.
-
Neurofeedback for the Education of Children with ADHD and Specific Learning Disorders: A Review.Brain Sci. 2022 Sep 14;12(9):1238. doi: 10.3390/brainsci12091238. Brain Sci. 2022. PMID: 36138974 Free PMC article. Review.
-
Experiences of neurofeedback therapists in treating attention-deficit hyperactivity disorder.Health SA. 2022 Jul 28;27:1874. doi: 10.4102/hsag.v27i0.1874. eCollection 2022. Health SA. 2022. PMID: 35937426 Free PMC article.
References
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
-
- Gadow KD, Sprafkin J, Nolan EE. DSM-IV symptoms in community and clinic preschool children. J Am Acad Child Adolesc Psychiatry. 2001;40(12):1383–1392. - PubMed
-
- Coon ER, Quinonez RA, Moyer VA, Schroeder AR. Overdiagnosis: how our compulsion for diagnosis may be harming children. Pediatrics. 2014;134(5):1013–1023. - PubMed
-
- Jensen PS. Current concepts and controversies in the diagnosis and treatment of attention deficit hyperactivity disorder. Curr Psychiatry Rep. 2000;2(2):102–109. - PubMed
Publication types
LinkOut - more resources
Full Text Sources